4:54 pm Chelsea Therapeutics confirms FDA accelerated approval of NORTHERA (droxidopa) for the treatment of symptomatic NOH (stock halted)
moreView todays social media effects on CHTPView the latest stocks trending across Twitter. Click to view dashboardSee who Chelsea is hiring next, click here to view […]